France· FR:64090124
FENOFIBRATE CRISTERS 160 mg, comprimé
A fenofibrate product containing fénofibrate, registered in France by CRISTERS, on the national reimbursement list. The same ATC class is registered in 15 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Fenofibrate is registered in 15 of 19 countries.
Countries holding a registration under ATC C10AB05 (fenofibrate), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 10 of them publish a price we can compare per daily dose
Fenofibrate · ATC C10AB05
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Finlandprice
- Franceprice
- Germany
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of fenofibrate costs, country by country.
Normalised to the WHO defined daily dose (0.2 g), the median price runs from $0.22 in Spain to $1.30 in United States — a ×5.8 gap.
- France: $0.24 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Fenofibrate · price per daily dose (0.2 g)
USD · FX 28 Sept 2026
- US United States$1.30 (acquisition cost)
- CH Switzerland$0.75
- IT Italy$0.35
- FR France$0.24
- ES Spain$0.22
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- FÉNOFIBRATE
- Manufacturer
- CRISTERS
- Country
- France (FR)
- ATC code
- C10AB05
- ATC class
- Fenofibrate
- Defined daily dose
- 0.2 g, O
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 2
2 priced- cip133400937325776plaquette(s) aluminium PVC PVDC de 90 comprimé(s)EUR 14.89
- cip133400937347488plaquette(s) aluminium PVC PVDC de 30 comprimé(s)EUR 5.01
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
268 interactions on record for fenofibrate.
Graded by severity as the source publishes them — 10 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Fenofibrate · interactions on record
268 records
- 10 severe
- 75 moderate
- 183 info
Most severe, free to view
- DicoumarolB01AA01severe
- WarfarinB01AA03severe
- SimvastatinC10AA01severe
- RosuvastatinC10AA07severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Fenofibrate in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesfenofibrateBryant Ranch Prepack
- United KingdomFenofibrate micronised 160mg tabletsA A H Pharmaceuticals Ltd
- CanadaAA-FENO-SUPERAA PHARMA INC
- NorwayFenofibrat heumannHeumann Pharma
- CzechiaFENOFIXTeva Pharmaceuticals CR, s.r.o., Praha
- PolandApo-Feno 200MAurovitas Pharma Polska Sp. z o.o.
- BelgiumCholib 145 mg - 40 mgViatris Healthcare
- SpainFENOFIBRATO AUROVITAS 145 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGAurovitas Spain, S.A.U.
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Fenolip Retard, Lipcor
- Belgium · Fenofibraat Eg, Fenofibrate Ab
- Bulgaria · Липантил, Липантил Супра
- Cyprus · Lipidil Nt
- Czechia · Fenofix, Fortilip
- Germany · Cil, Elipsia
- Estonia · Lipanthyl
- Spain · Fenofibrate Teva, Fenofibrato Aurovitas
- Finland · Lipanthyl Penta
- United Kingdom (Northern Ireland) · Fenofibrate, Fenofibrate Accord Uk
- Greece · Fenobrat, Lipidil Nt
- Croatia · Fenolip, Tricor
- Hungary · Fenobrat, Fenoswiss
- Ireland · Lipantil Micro, Lipantil Supra
- Italy · Fenofibrato Aurobindo, Fenofibrato Eg
- Lithuania · Lipanthyl
- Luxembourg · Fenofibraat Eg, Fenogal Lidose
- Latvia · Lipanthyl
- Malta · Lipantil Supra
- Netherlands · Fenogal
- Norway · Thylip
- Poland · Biofibrat, Fenardin
- Portugal · Catalip, Catalip Micronizado
- Romania · Fenofibrat Terapia, Lipanthyl Supra
- Sweden · Lipanthyl, Thylip
- Slovenia · Katalip
- Slovakia · Fenofibrate Teva, Fenofix
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b0dc6d18-01a9-47ad-91af-8ffbe356b96b GET /v1/drugs/b0dc6d18-01a9-47ad-91af-8ffbe356b96b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "64090124",
"date_amm": "2006-02-08",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "FÉNOFIBRATE",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": "Warning disponibilité",
"forme_pharmaceutique": "comprimé",
"voies_administration": "orale",
"etat_commercialisation": "Non commercialisée",
"surveillance_renforcee": "Non"
}See everything about fenofibrate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.